Loading clinical trials...
Loading clinical trials...
The main objective of the surveillance is to evaluate the incidence of the adverse events (AEs), and other safety-related information in South-Korean population.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ModernaTX, Inc.
Collaborators
NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT05141058 · SARS-CoV-2 Infection
NCT06679140 · COVID-19 SARS-CoV-2 Infection
NCT06160128 · COVID-19, SARS-CoV-2 Infection, RSV, and more
Yonseimin Clinic
Wŏnju, Gangwon-do
Hyundai Clinic
Bucheon-si, Gyeonggi-do
Ma Hak ki Family Medicine Clinic
Bucheon-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions